The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
SCYNEXIS, Inc(NASDAQ:SCYX) 
SCYNEXIS, Inc., a biotechnology company, delivers therapies for the treatment fungal infections in the United States. It is developing its lead product candidate, ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including vulvovaginal candidiasis, i...
Website: http://www.scynexis.com
Full Time Employees: 27
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
SCYNEXIS Days Payable Outstanding ttm (DPO)
SCYNEXIS Days Receivable Outstanding ttm (DSO)
SCYNEXIS Days Inventory Outstanding ttm (DIO)
SCYNEXIS Op Cashflow Per Share ttm
SCYNEXIS Free Cashflow Per Share ttm
SCYNEXIS Cash Per Share ttm
SCYNEXIS P/S ratio ttm
SCYNEXIS (GAAP) P/E ratio ttm
SCYNEXIS P/B ratio ttm
No extra charts and metrics for this ticker.